Evidence map›Paper›PMID 30913539›Full record

ArticleEndocrine connections2019

The avian chorioallantoic membrane as an alternative tool to study medullary thyroid cancer.

Nassim Ghaffari-Tabrizi-Wizsy, Christina Angelika Passegger, Laura Nebel, Fabian Krismer, Gudrun Herzer-Schneidhofer, Gert Schwach, Roswitha Pfragner

Abstract read
In one paragraph

Article in Endocrine connections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Oncology reports · 2023
    Article
  5. Disease Animal Models for Cancer Research.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Review
  7. Frontiers in immunology · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nassim Ghaffari-Tabrizi-WizsyOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Christina Angelika PasseggerOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Laura NebelOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Fabian KrismerOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Gudrun Herzer-SchneidhoferOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Gert SchwachOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.
Roswitha PfragnerOtto Loewi Research Center - Immunology and Pathophysiology, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preclinical trials of medullary thyroid cancer (MTC) therapeutics require both in vitro and in vivo analyses. Human tumour xenografted rodent models, which are considered the 'gold standard' to study and validate the efficacy and toxicity of lead compounds before translation to clinical trials, are very expensive, subject to organismal variability and ethical controversies. The avian chorioallantoic membrane (CAM) assay provides an alternative versatile, cost-effective and ethically less objectionable short-term, in vivo model for reliable screening of drugs. In this work, we grafted two MTC cell lines and patient-derived MTC tumour samples onto the avian CAM and characterised the resulted tumours histologically and immunohistochemically. Our findings provide the evidence that the CAM assay is a suitable model for studying the pathophysiology of MTC and can even be used as in vivo system for drug testing.

Indexed as

3Rendocrine cancersmedullary thyroid carcinomaprecilinal trials

Identifiers

PMID30913539
PMCPMC6479196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.